IL-2 therapy provides no clinical benefit to HIV-infected patients on ART.
D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D011379:Prognosis
D044966:Anti-Retroviral Agents; D007376:Interleukin-2